Membership

Endocrine Cancers SIG

September 06, 2022

Discuss advancements in understanding and treating endocrine cancers and collaborate with colleagues on the best avenues for care. By becoming a member of the Endocrine Cancers SIG, you will be the first to know about the SIG’s educational content and networking activities. Sign up today! Engage with your peers in the SIG DocMatter subgroup.

View the Endocrine Cancers leadership roster


Upcoming Event: Medullary Thyroid Cancer 

Friday, February 3, 2023, 10:00 AM–11:40 AM EST

Learning Objectives:

  1. Learn how to avoid the pitfalls in pre-operative diagnosis of medullary thyroid cancer. 
  2. Discuss the current landscape of systemic therapy in advanced medullary thyroid cancer. 
  3. Explore neo-adjuvant therapy in the setting of advanced medullary thyroid cancer.

Speakers:

Mimi I. Hu, MD
Professor
The University of Texas MD Anderson Cancer Center

Gregory Randolph, MD, FACS, FACE
Professor of Otolaryngology–Head and Neck Surgery
Claire and John Bertucci Endowed Chair in Thyroid Surgical Oncology
Harvard Medical School
Director, Thyroid and Parathyroid Endocrine Surgical Division
Massachusetts Eye and Ear 

Case Presenters: 

Anupam Kotwol, MD
Assistant Professor, Division of Diabetes, Endocrinology, and Metabolism 
UNMC Nebraska Medicine 

Trisha Cubb, MD
Endocrinologist
Houston Methodist Hospital 
Assistant Professor of Clinical Medicine
Academic Institute at Houston Methodist Hospital 
Weill Cornell Medical College 

 

Upcoming Event: Adrenocortical Carcinoma: The Latest Pre-Clinical and Clinical Updates

Friday, February 17, 2023, 11:00 AM-12 PM EST 

Learning Objectives

  1. Review the essential clinical features of adrenocortical carcinoma (ACC)
  2. Discuss the translational research in ACC 
  3. Summarize treatment options for localized and advanced ACC

Speakers:

Mouhammed Habra, Md, FACP, FACE 
Professor 
Chief, Section of Endocrine Neoplasia
Department of Endocrine Neoplasia and Hormonal Disorders 
The University of Texas MD Anderson Cancer Center

Katja Kiseljak-Vassiliades, DO 
Associate Professor 
University of Colorado School of Medicine
Anschutz Medical Campus
Department of Internal Medicine
Division of Endocrinology, Metabolism and Diabetes

Moderator:

Inga Harbuz Miller, MD
Assistant Professor
University of Rochester 


Past Events

Causes, Diagnosis, and Treatment of Parathyroid Cancer

September 1, 2022

Faculty:
Maria Luisa Brandi, MD, PhD
Professor of Endocrinology
University of Florence

Case Presenter:
Briana Cortez
MD/MPH Student
University of Texas Rio Grande Valley School of Medicine

Moderator:
Sunita Agarwal, PhD
Staff Scientist
NIDDK, NIH

Learning Objectives:

  1. Understand the pathogenesis and genetic pathways of parathyroid cancer.
  2. Recognize the symptoms of diagnostic process for parathyroid cancer.
  3. Gain an update on the surgical and pharmacological management of the disease, including the newest treatment options.

Watch the event on-demand.

Endocrine Cancers SIG held a webinar on the diagnosis, surgical management, and latest therapies for anaplastic thyroid cancer. This event was held April 27, 2022.

Learning Objectives

  • 1. Describe the important tests for diagnosing and staging anaplastic thyroid cancer.

  • 2. Identify important factors for the optimal surgical management of anaplastic thyroid cancer.

  • 3. Describe evidence-based therapies for anaplastic thyroid cancer.

Speakers:

  • Electron Kebebew, MD, FACS, Harry A. Oberhelman Jr and Mark L. Welton Professor and Chief of General Surgery, Stanford University Health

  • Maria Cabanillas, MD, Oncologic Endocrinologist University of Texas MD Anderson Cancer Center

Moderators:

  • Zeina Hannoush, MD Assistant Clinical Professor University of Miami Health System

  • Samira Sadowski, MD Physician-Scientist Early Investigator National Cancer Institute, Center for Cancer Research

Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.